Glutamate and lipid metabolic perturbation in the hippocampi of asymptomatic borna disease virus-infected horses

PLoS One. 2014 Jun 23;9(6):e99752. doi: 10.1371/journal.pone.0099752. eCollection 2014.

Abstract

Borna disease virus (BDV) is a neurotropic, enveloped, non-segmented, negative-stranded RNA virus that infects a wide variety of vertebrate species from birds to humans across a broad global geographic distribution. Animal symptomatology range from asymptomatic infection to behavioral abnormalities to acute meningoencephalitis. Asymptomatic BDV infection has been shown to be more frequent than conventionally estimated. However, the molecular mechanism(s) underyling asymptomatic BDV infection remain largely unknown. Here, based on real-time quantitative PCR and Western blotting, a total of 18 horse hippocampi were divided into BDV-infected (n = 8) and non-infected control (n = 10) groups. A gas chromatography coupled with mass spectrometry (GC-MS) metabolomic approach, in conjunction with multivariate statistical analysis, was used to characterize the hippocampal metabolic changes associated with asymptomatic BDV infection. Multivariate statistical analysis showed a significant discrimination between the BDV-infected and control groups. BDV-infected hippocampi were characterized by lower levels of D-myo-inositol-1-phosphate, glutamate, phosphoethanolamine, heptadecanoic acid, and linoleic acid in combination with a higher level of ammonia. These differential metabolites are primarily involved in glutamate and lipid metabolism. These finding provide an improved understanding of hippocampal changes associated with asymptomatic BDV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Borna Disease / metabolism*
  • Borna Disease / pathology
  • Borna disease virus / metabolism*
  • Glutamic Acid / metabolism*
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • Hippocampus / virology
  • Horse Diseases / metabolism*
  • Horse Diseases / pathology
  • Horses
  • Lipid Metabolism*

Substances

  • Glutamic Acid

Grants and funding

This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300) (http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.